Insider · CIK 0001797376

Michael D. Castagnetto

officer

Files at CHRW (C. H. ROBINSON WORLDWIDE, INC.). First filing Jan 3, 2025, latest Feb 20, 2025.

Track record

Not enough history

Fewer than three past buys with six months of prices.

Median 6-month excess

after past buys, n = 0

Hit rate

past buys that beat the index over 6 months

Open-market trades

0 / 2

$0 bought, $711k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CHRW: C. H. ROBINSON WORLDWIDE, INC.

CHRWOct 9, 2026 · close 142.31

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

Score	Company	Value	Holdings	Price context	Filed
33Weak	CHRWsell 310b5-1 C. H. ROBINSON WORLDWIDE, INC.	$500k 5,016 shares	-13%	-	Feb 20, 2025
7Weak	CHRWsell10b5-1 C. H. ROBINSON WORLDWIDE, INC.	$211k 2,032 shares	-6%	-	Jan 3, 2025

Transactions

Every row this insider has filed, newest first.

Date	Company	Transaction	Shares	Price	Value	Holdings after	Filed
Feb 18, 2025	CHRW C. H. ROBINSON WORLDWIDE, INC.	FTax withholding Common Stock10b5-1	-2,284	$99.49	$227k	39,602	Feb 20, 2025
Feb 18, 2025	CHRW C. H. ROBINSON WORLDWIDE, INC.	SOpen-market sale Common Stock10b5-1	-5,016	$99.60	$500k	34,586	Feb 20, 2025
Feb 5, 2025	CHRW C. H. ROBINSON WORLDWIDE, INC.	AGrant or award Common Stock	+6,930	$0.00	$0	41,399	Feb 7, 2025
Feb 5, 2025	CHRW C. H. ROBINSON WORLDWIDE, INC.	AGrant or award Common Stock	+487	$0.00	$0	41,886	Feb 7, 2025
Dec 31, 2024	CHRW C. H. ROBINSON WORLDWIDE, INC.	FTax withholding Common Stock10b5-1	-897	$103.48	$93k	36,346	Jan 3, 2025
Dec 31, 2024	CHRW C. H. ROBINSON WORLDWIDE, INC.	SOpen-market sale Common Stock10b5-1	-2,032	$103.81	$211k	34,469	Jan 3, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.